NasdaqGM - Nasdaq Real Time Price USD
Corvus Pharmaceuticals, Inc. (CRVS)
3.6600
+0.1400
+(3.98%)
At close: April 24 at 4:00:01 PM EDT
3.7775
+0.12
+(3.21%)
After hours: April 24 at 7:59:12 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
68,907
45,553
68,240
109,455
Total Liabilities Net Minority Interest
36,339
6,869
12,125
12,293
Total Equity Gross Minority Interest
32,568
38,684
56,115
97,162
Total Capitalization
32,568
38,684
56,115
97,162
Common Stock Equity
32,568
38,684
56,115
97,162
Capital Lease Obligations
1,122
1,374
2,601
3,647
Net Tangible Assets
32,568
38,684
56,115
97,162
Working Capital
19,005
21,087
32,912
61,620
Invested Capital
32,568
38,684
56,115
97,162
Tangible Book Value
32,568
38,684
56,115
97,162
Total Debt
1,122
1,374
2,601
3,647
Share Issued
64,257.2510
49,038.5820
46,553.5110
46,553.5110
Ordinary Shares Number
64,257.2510
49,038.5820
46,553.5110
46,553.5110
12/31/2021 - 3/23/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LPTX Leap Therapeutics, Inc.
0.3931
-0.48%
NKTR Nektar Therapeutics
0.7383
+7.66%
PDSB PDS Biotechnology Corporation
1.3200
+7.32%
LRMR Larimar Therapeutics, Inc.
2.3700
+4.87%
ALEC Alector, Inc.
1.1800
+1.72%
MREO Mereo BioPharma Group plc
2.5400
-0.78%
CRDF Cardiff Oncology, Inc.
2.9000
-1.36%
ABEO Abeona Therapeutics Inc.
5.39
+3.26%
VNDA Vanda Pharmaceuticals Inc.
4.3100
-0.46%
ALMS Alumis Inc.
4.3100
-8.49%